tirzepatide cas | C225H348N48O68 | CID 156588324 Tirzepatide GLP-1 Tirze, CasNo.2023788-19-2 Hangzhou
Description
4 0,5
Review all concurrent medications with your healthcare provider, identifying any that promote weight gain or interfere with metabolic pathways
Outcomes outside of the testing hierarchy, such as occurrence of diabetes-related morbidity (e.g., individual component of MACE or expanded composite CV outcome), change in blood pressure, and HRQoL, need to be interpreted with caution due to the possible inflated type I error
Some 52% say they feel more positive about their appearance
Monitor your blood glucose levels carefully, as both hypoglycaemia and hyperglycaemia can affect mood and cognitive function
